Purchase Order N0025920P0098

Award Date 1/6/20
Potential Completion Date 1/9/21
Potential Value $249K
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Knoxville, TN 37932, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
2
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Navy Bureau of Medicine and Surgery awarded a firm-fixed-price purchase order to Petnet Solutions, Inc., a subsidiary of Siemens AG, for the provision of positron emission tomography (PET) radiopharmaceuticals. The contract, valued at $214,633.00, does not have a set-aside designation and was awarded on January 10, 2019 with a completion date of March 28, 2022. Petnet Solutions is a manufacturer of radioactive imaging agents and calibration sources used in nuclear...
This federal contract award to Petnet Solutions, Inc. is for the provision of Positron Emission Tomography (PET) radiopharmaceuticals to the Department of the Navy Bureau of Medicine and Surgery. The one-year, firm-fixed price purchase order has a potential value of $149,999.00 and includes PET imaging agents such as F-18 FDG, F-18 Amyvid, and F-18 Axumin used to diagnose cancer, neurological disorders, and cardiac disease. Petnet Solutions, Inc. is a subsidiary of the Siemens AG conglomerate...
The Defense Health Agency awarded a $249,000.00 firm fixed price purchase order to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft, to provide Positron Emission Tomography (PET) radiopharmaceuticals. This sole source award, issued without a set aside, supports the supply of specialized PET imaging agents such as Fluorodeoxyglucose F-18 (FDG), Sodium Fluoride F-18 (NaF), Axumin, and Amyvid to the Naval Medical Center San Diego. As a key supplier of radiopharmaceuticals to...
This is a firm-fixed-price contract awarded by the Department of Veterans Affairs (VA) to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft, to provide radiopharmaceuticals including 250 units annually of F-18 NaF PET Bone and 950 units annually of F-18 FDG PET. The contract, valued at $706,405.76, covers the base year from May 1, 2024 to April 30, 2025, with subsequent option years. The original solicitation was not set aside and was issued under NAICS code 325412 with a size...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft, for the supply of emergency AMYVID (florbetapir F-18) radiopharmaceutical. The contract has a ceiling value of $9,087.00 and an ultimate completion date of May 31, 2025. Petnet Solutions is a critical supplier of specialized radiopharmaceutical products used in positron emission tomography (PET) and computed tomography (CT) scans to...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft. The contract is for the delivery of specialized radiopharmaceutical products used in positron emission tomography (PET) and computed tomography (CT) scans, with a ceiling value of $576,745.00. The products include fluorodeoxyglucose (FDG), Axumin (fluciclovine F-18), Amyvid (florbetapir F-18), and...
This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 22 (VISN 22) of the Department of Veterans Affairs (VA) to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft. The contract is for the delivery of F18 radiopharmaceuticals, which are used in positron emission tomography (PET) and computed tomography (CT) scans to diagnose conditions like cancer, neurological disorders, and cardiac diseases. The contract has a ceiling value of $89,720.00...
This is a $196,947.70 firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Petnet Solutions, Inc., a subsidiary of the global technology conglomerate Siemens Aktiengesellschaft. The contract is for the supply of various radiopharmaceutical products, including fluorodeoxyglucose (FDG), Axumin, Amyvid, and Tauvid, to support the Department of Radiology Nuclear Medicine Services at Madigan Army Medical Center (MAMC) in Tacoma, Washington. The contract was awarded...
This is a firm fixed-price purchase order awarded by the Department of Veterans Affairs (VA) to Petnet Solutions, Inc., a subsidiary of Siemens Aktiengesellschaft, a foreign-owned, for-profit manufacturer of specialized radiopharmaceutical products. The contract, valued at $97,719.48, is for the delivery of medical imaging agents such as fluorodeoxyglucose (FDG), Axumin, Amyvid, and Tauvid, which are used in positron emission tomography (PET) and computed tomography (CT) scans to diagnose...
This is a firm fixed-price contract awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Petnet Solutions, Inc., a subsidiary of the global technology company Siemens Aktiengesellschaft. The contract, valued at $150,000.00, is for the provision of radiopharmaceutical products used in medical imaging procedures such as PET and CT scans. These specialized imaging agents are critical for diagnosing conditions like cancer, neurological disorders, and cardiac diseases across...

This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery (BUMED) of the U.S. Navy for the provision of radiopharmaceuticals used in positron emission tomography (PET) and computed tomography (CT) medical imaging procedures. The products to be delivered include fluorodeoxyglucose (FDG), sodium fluoride F-18 (NaF), Axumin (fluciclovine F-18), and Amyvid (florbetapir F-18). The contract has a ceiling value of $249,000.00 and a period of performance through January 9, 2021. The prime contractor is Petnet Solutions, Inc., a subsidiary of the global technology conglomerate Siemens Aktiengesellschaft. This contract is not set aside for any socioeconomic category. The radiopharmaceuticals provided under this contract are critical for diagnosing and monitoring various medical conditions, including cancer, neurological disorders, and cardiac diseases, across federal healthcare systems such as the Department of Veterans Affairs (VA) and Defense Health Agency (DHA).

Generated 5/16/25, 12:31 PM